Loading...
Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
The improvement in outcomes of adult patients with acute lymphoblastic leukemia (ALL) has been modest, with the exception of Philadelphia chromosome-positive disease, despite advances in supportive care and stem cell transplantation. The recent approvals of novel agents, including the bispecific T-c...
Na minha lista:
| Udgivet i: | J Blood Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5908210/ https://ncbi.nlm.nih.gov/pubmed/29713210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S136575 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|